nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Fluorouracil—head and neck cancer	0.311	0.46	CbGbCtD
Montelukast—CYP2C8—Fluorouracil—head and neck cancer	0.153	0.227	CbGbCtD
Montelukast—CYP2C9—Fluorouracil—head and neck cancer	0.107	0.158	CbGbCtD
Montelukast—CYP3A4—Vinblastine—head and neck cancer	0.0575	0.0852	CbGbCtD
Montelukast—CYP3A4—Docetaxel—head and neck cancer	0.0474	0.0702	CbGbCtD
Montelukast—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX1—head and neck cancer	0.0135	0.095	CbGpPWpGaD
Montelukast—CYP2A6—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00396	0.0278	CbGpPWpGaD
Montelukast—Foetor hepaticus—Docetaxel—head and neck cancer	0.0036	0.0198	CcSEcCtD
Montelukast—Disorientation—Hydroxyurea—head and neck cancer	0.00319	0.0175	CcSEcCtD
Montelukast—Liver disorder—Docetaxel—head and neck cancer	0.00299	0.0164	CcSEcCtD
Montelukast—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00298	0.0209	CbGpPWpGaD
Montelukast—CYSLTR1—G alpha (q) signalling events—KISS1—head and neck cancer	0.00277	0.0195	CbGpPWpGaD
Montelukast—Dermatitis atopic—Docetaxel—head and neck cancer	0.00276	0.0151	CcSEcCtD
Montelukast—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00271	0.019	CbGpPWpGaD
Montelukast—CYP2A6—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00263	0.0185	CbGpPWpGaD
Montelukast—ALOX5—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.00263	0.0184	CbGpPWpGaD
Montelukast—Otitis media—Docetaxel—head and neck cancer	0.00262	0.0144	CcSEcCtD
Montelukast—Rhinorrhoea—Docetaxel—head and neck cancer	0.00252	0.0138	CcSEcCtD
Montelukast—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00251	0.0176	CbGpPWpGaD
Montelukast—ALOX5—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00248	0.0174	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.00248	0.0174	CbGpPWpGaD
Montelukast—ALOX5—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00246	0.0172	CbGpPWpGaD
Montelukast—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00243	0.017	CbGpPWpGaD
Montelukast—Pancreatitis—Hydroxyurea—head and neck cancer	0.00242	0.0133	CcSEcCtD
Montelukast—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00236	0.013	CcSEcCtD
Montelukast—Disorientation—Fluorouracil—head and neck cancer	0.00229	0.0126	CcSEcCtD
Montelukast—CYSLTR1—G alpha (q) signalling events—GRP—head and neck cancer	0.00228	0.016	CbGpPWpGaD
Montelukast—Bone disorder—Docetaxel—head and neck cancer	0.00226	0.0124	CcSEcCtD
Montelukast—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00221	0.0155	CbGpPWpGaD
Montelukast—Drowsiness—Hydroxyurea—head and neck cancer	0.0022	0.0121	CcSEcCtD
Montelukast—Infestation—Hydroxyurea—head and neck cancer	0.0022	0.0121	CcSEcCtD
Montelukast—Infestation NOS—Hydroxyurea—head and neck cancer	0.0022	0.0121	CcSEcCtD
Montelukast—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00215	0.0118	CcSEcCtD
Montelukast—Hypoaesthesia—Vinblastine—head and neck cancer	0.00215	0.0118	CcSEcCtD
Montelukast—Pharyngitis—Vinblastine—head and neck cancer	0.00215	0.0118	CcSEcCtD
Montelukast—CYP2A6—Xenobiotics—CYP1A1—head and neck cancer	0.0021	0.0147	CbGpPWpGaD
Montelukast—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00208	0.0114	CcSEcCtD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.00204	0.0143	CbGpPWpGaD
Montelukast—Hepatocellular injury—Docetaxel—head and neck cancer	0.00204	0.0112	CcSEcCtD
Montelukast—CYP2A6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00202	0.0142	CbGpPWpGaD
Montelukast—Hallucination—Hydroxyurea—head and neck cancer	0.00196	0.0108	CcSEcCtD
Montelukast—Irritability—Fluorouracil—head and neck cancer	0.00196	0.0108	CcSEcCtD
Montelukast—Neuropathy—Docetaxel—head and neck cancer	0.00192	0.0105	CcSEcCtD
Montelukast—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00188	0.0132	CbGpPWpGaD
Montelukast—CYP2A6—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00187	0.0131	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00184	0.0129	CbGpPWpGaD
Montelukast—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00183	0.0101	CcSEcCtD
Montelukast—Eosinophilia—Fluorouracil—head and neck cancer	0.00176	0.00965	CcSEcCtD
Montelukast—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—head and neck cancer	0.00175	0.0123	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00166	0.0116	CbGpPWpGaD
Montelukast—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00165	0.00906	CcSEcCtD
Montelukast—Convulsion—Vinblastine—head and neck cancer	0.00163	0.00896	CcSEcCtD
Montelukast—Pneumonia—Fluorouracil—head and neck cancer	0.00159	0.00874	CcSEcCtD
Montelukast—Infestation NOS—Fluorouracil—head and neck cancer	0.00158	0.00869	CcSEcCtD
Montelukast—Infestation—Fluorouracil—head and neck cancer	0.00158	0.00869	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00158	0.0111	CbGpPWpGaD
Montelukast—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00155	0.00852	CcSEcCtD
Montelukast—Conjunctivitis—Fluorouracil—head and neck cancer	0.00154	0.00845	CcSEcCtD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00151	0.0106	CbGpPWpGaD
Montelukast—Thrombocytopenia—Vinblastine—head and neck cancer	0.0015	0.00827	CcSEcCtD
Montelukast—CYP2A6—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.0015	0.0105	CbGpPWpGaD
Montelukast—Epistaxis—Fluorouracil—head and neck cancer	0.00149	0.0082	CcSEcCtD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.00149	0.0105	CbGpPWpGaD
Montelukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00149	0.0105	CbGpPWpGaD
Montelukast—Convulsion—Hydroxyurea—head and neck cancer	0.00149	0.00817	CcSEcCtD
Montelukast—Sinusitis—Fluorouracil—head and neck cancer	0.00148	0.00815	CcSEcCtD
Montelukast—ALOX5—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00146	0.0103	CbGpPWpGaD
Montelukast—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00146	0.0102	CbGpPWpGaD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00145	0.00798	CcSEcCtD
Montelukast—PTGS1—Overview of nanoparticle effects—BCL2—head and neck cancer	0.00145	0.0102	CbGpPWpGaD
Montelukast—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.00143	0.0101	CbGpPWpGaD
Montelukast—Rhinitis—Fluorouracil—head and neck cancer	0.00142	0.00782	CcSEcCtD
Montelukast—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00141	0.00776	CcSEcCtD
Montelukast—Pharyngitis—Fluorouracil—head and neck cancer	0.00141	0.00774	CcSEcCtD
Montelukast—Oedema—Hydroxyurea—head and neck cancer	0.0014	0.0077	CcSEcCtD
Montelukast—CYSLTR1—GPCR ligand binding—KISS1—head and neck cancer	0.0014	0.00981	CbGpPWpGaD
Montelukast—Infection—Hydroxyurea—head and neck cancer	0.00139	0.00765	CcSEcCtD
Montelukast—Paraesthesia—Vinblastine—head and neck cancer	0.00138	0.00758	CcSEcCtD
Montelukast—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00138	0.00967	CbGpPWpGaD
Montelukast—PTGS1—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.00137	0.00964	CbGpPWpGaD
Montelukast—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00137	0.00755	CcSEcCtD
Montelukast—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00137	0.00754	CcSEcCtD
Montelukast—Skin disorder—Hydroxyurea—head and neck cancer	0.00136	0.00748	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00133	0.00733	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00133	0.00733	CcSEcCtD
Montelukast—Cramp muscle—Docetaxel—head and neck cancer	0.00133	0.00733	CcSEcCtD
Montelukast—Nasopharyngitis—Docetaxel—head and neck cancer	0.00132	0.00728	CcSEcCtD
Montelukast—Pain—Vinblastine—head and neck cancer	0.00131	0.00722	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00131	0.00718	CcSEcCtD
Montelukast—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00126	0.0069	CcSEcCtD
Montelukast—Somnolence—Hydroxyurea—head and neck cancer	0.00125	0.00685	CcSEcCtD
Montelukast—Dyspepsia—Hydroxyurea—head and neck cancer	0.00123	0.00678	CcSEcCtD
Montelukast—Abdominal pain—Vinblastine—head and neck cancer	0.00121	0.00667	CcSEcCtD
Montelukast—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00121	0.00665	CcSEcCtD
Montelukast—Fatigue—Hydroxyurea—head and neck cancer	0.00121	0.00664	CcSEcCtD
Montelukast—Pain—Hydroxyurea—head and neck cancer	0.0012	0.00658	CcSEcCtD
Montelukast—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.00117	0.00824	CbGpPWpGaD
Montelukast—CYSLTR1—Endothelins—MAPK3—head and neck cancer	0.00117	0.00819	CbGpPWpGaD
Montelukast—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.00117	0.00818	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—GRP—head and neck cancer	0.00115	0.00808	CbGpPWpGaD
Montelukast—Pneumonia—Docetaxel—head and neck cancer	0.00115	0.00631	CcSEcCtD
Montelukast—Infestation NOS—Docetaxel—head and neck cancer	0.00114	0.00627	CcSEcCtD
Montelukast—Infestation—Docetaxel—head and neck cancer	0.00114	0.00627	CcSEcCtD
Montelukast—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.00114	0.008	CbGpPWpGaD
Montelukast—Hypersensitivity—Vinblastine—head and neck cancer	0.00113	0.00622	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00113	0.00622	CcSEcCtD
Montelukast—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00112	0.00787	CbGpPWpGaD
Montelukast—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00112	0.00615	CcSEcCtD
Montelukast—Jaundice—Docetaxel—head and neck cancer	0.00111	0.00611	CcSEcCtD
Montelukast—CYSLTR1—Endothelins—MAPK1—head and neck cancer	0.00111	0.0078	CbGpPWpGaD
Montelukast—Conjunctivitis—Docetaxel—head and neck cancer	0.00111	0.0061	CcSEcCtD
Montelukast—Body temperature increased—Hydroxyurea—head and neck cancer	0.00111	0.00609	CcSEcCtD
Montelukast—Asthenia—Vinblastine—head and neck cancer	0.0011	0.00606	CcSEcCtD
Montelukast—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00108	0.00593	CcSEcCtD
Montelukast—Epistaxis—Docetaxel—head and neck cancer	0.00108	0.00592	CcSEcCtD
Montelukast—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00108	0.00755	CbGpPWpGaD
Montelukast—Convulsion—Fluorouracil—head and neck cancer	0.00107	0.00588	CcSEcCtD
Montelukast—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00107	0.00748	CbGpPWpGaD
Montelukast—Myalgia—Fluorouracil—head and neck cancer	0.00105	0.00578	CcSEcCtD
Montelukast—Diarrhoea—Vinblastine—head and neck cancer	0.00105	0.00578	CcSEcCtD
Montelukast—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00103	0.00567	CcSEcCtD
Montelukast—Rhinitis—Docetaxel—head and neck cancer	0.00103	0.00564	CcSEcCtD
Montelukast—Hepatitis—Docetaxel—head and neck cancer	0.00102	0.00563	CcSEcCtD
Montelukast—Hypoaesthesia—Docetaxel—head and neck cancer	0.00102	0.0056	CcSEcCtD
Montelukast—Pharyngitis—Docetaxel—head and neck cancer	0.00102	0.00559	CcSEcCtD
Montelukast—Dizziness—Vinblastine—head and neck cancer	0.00102	0.00558	CcSEcCtD
Montelukast—Urinary tract disorder—Docetaxel—head and neck cancer	0.00101	0.00556	CcSEcCtD
Montelukast—Oedema—Fluorouracil—head and neck cancer	0.00101	0.00554	CcSEcCtD
Montelukast—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00101	0.00554	CcSEcCtD
Montelukast—Connective tissue disorder—Docetaxel—head and neck cancer	0.00101	0.00553	CcSEcCtD
Montelukast—Asthenia—Hydroxyurea—head and neck cancer	0.00101	0.00552	CcSEcCtD
Montelukast—Urethral disorder—Docetaxel—head and neck cancer	0.001	0.00552	CcSEcCtD
Montelukast—Infection—Fluorouracil—head and neck cancer	0.001	0.00551	CcSEcCtD
Montelukast—Nervous system disorder—Fluorouracil—head and neck cancer	0.000989	0.00544	CcSEcCtD
Montelukast—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000987	0.00543	CcSEcCtD
Montelukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000982	0.00689	CbGpPWpGaD
Montelukast—Vomiting—Vinblastine—head and neck cancer	0.000977	0.00537	CcSEcCtD
Montelukast—Erythema multiforme—Docetaxel—head and neck cancer	0.000969	0.00532	CcSEcCtD
Montelukast—Headache—Vinblastine—head and neck cancer	0.000962	0.00529	CcSEcCtD
Montelukast—Diarrhoea—Hydroxyurea—head and neck cancer	0.000959	0.00527	CcSEcCtD
Montelukast—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.000953	0.00669	CbGpPWpGaD
Montelukast—Cardiac disorder—Docetaxel—head and neck cancer	0.000951	0.00523	CcSEcCtD
Montelukast—ALOX5—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00093	0.00652	CbGpPWpGaD
Montelukast—Dizziness—Hydroxyurea—head and neck cancer	0.000927	0.00509	CcSEcCtD
Montelukast—Immune system disorder—Docetaxel—head and neck cancer	0.000925	0.00509	CcSEcCtD
Montelukast—Mediastinal disorder—Docetaxel—head and neck cancer	0.000923	0.00507	CcSEcCtD
Montelukast—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000919	0.00645	CbGpPWpGaD
Montelukast—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000919	0.00505	CcSEcCtD
Montelukast—Nausea—Vinblastine—head and neck cancer	0.000913	0.00502	CcSEcCtD
Montelukast—Insomnia—Fluorouracil—head and neck cancer	0.000912	0.00501	CcSEcCtD
Montelukast—Paraesthesia—Fluorouracil—head and neck cancer	0.000906	0.00498	CcSEcCtD
Montelukast—Mental disorder—Docetaxel—head and neck cancer	0.000898	0.00493	CcSEcCtD
Montelukast—Somnolence—Fluorouracil—head and neck cancer	0.000897	0.00493	CcSEcCtD
Montelukast—CYSLTR1—Endothelins—HRAS—head and neck cancer	0.000892	0.00626	CbGpPWpGaD
Montelukast—Vomiting—Hydroxyurea—head and neck cancer	0.000891	0.0049	CcSEcCtD
Montelukast—Dyspepsia—Fluorouracil—head and neck cancer	0.000888	0.00488	CcSEcCtD
Montelukast—Rash—Hydroxyurea—head and neck cancer	0.000883	0.00486	CcSEcCtD
Montelukast—Dermatitis—Hydroxyurea—head and neck cancer	0.000883	0.00485	CcSEcCtD
Montelukast—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000882	0.00619	CbGpPWpGaD
Montelukast—Headache—Hydroxyurea—head and neck cancer	0.000878	0.00482	CcSEcCtD
Montelukast—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000871	0.00611	CbGpPWpGaD
Montelukast—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000871	0.00479	CcSEcCtD
Montelukast—Pain—Fluorouracil—head and neck cancer	0.000862	0.00474	CcSEcCtD
Montelukast—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000859	0.00603	CbGpPWpGaD
Montelukast—Muscle spasms—Docetaxel—head and neck cancer	0.000857	0.00471	CcSEcCtD
Montelukast—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000847	0.00594	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000838	0.00588	CbGpPWpGaD
Montelukast—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000836	0.00587	CbGpPWpGaD
Montelukast—Nausea—Hydroxyurea—head and neck cancer	0.000832	0.00457	CcSEcCtD
Montelukast—ALOX5—Metabolism—UROD—head and neck cancer	0.000804	0.00564	CbGpPWpGaD
Montelukast—Urticaria—Fluorouracil—head and neck cancer	0.000801	0.0044	CcSEcCtD
Montelukast—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000801	0.00562	CbGpPWpGaD
Montelukast—Body temperature increased—Fluorouracil—head and neck cancer	0.000797	0.00438	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—KISS1—head and neck cancer	0.00079	0.00554	CbGpPWpGaD
Montelukast—Palpitations—Docetaxel—head and neck cancer	0.000788	0.00433	CcSEcCtD
Montelukast—CYSLTR1—Endothelins—AKT1—head and neck cancer	0.000788	0.00553	CbGpPWpGaD
Montelukast—Cough—Docetaxel—head and neck cancer	0.000778	0.00428	CcSEcCtD
Montelukast—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000776	0.00545	CbGpPWpGaD
Montelukast—Convulsion—Docetaxel—head and neck cancer	0.000773	0.00425	CcSEcCtD
Montelukast—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000769	0.0054	CbGpPWpGaD
Montelukast—Myalgia—Docetaxel—head and neck cancer	0.000759	0.00417	CcSEcCtD
Montelukast—Arthralgia—Docetaxel—head and neck cancer	0.000759	0.00417	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000754	0.00414	CcSEcCtD
Montelukast—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000747	0.00524	CbGpPWpGaD
Montelukast—Hypersensitivity—Fluorouracil—head and neck cancer	0.000743	0.00408	CcSEcCtD
Montelukast—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000739	0.00519	CbGpPWpGaD
Montelukast—Oedema—Docetaxel—head and neck cancer	0.000728	0.004	CcSEcCtD
Montelukast—Anaphylactic shock—Docetaxel—head and neck cancer	0.000728	0.004	CcSEcCtD
Montelukast—Infection—Docetaxel—head and neck cancer	0.000723	0.00397	CcSEcCtD
Montelukast—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000718	0.00504	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—KISS1—head and neck cancer	0.000717	0.00503	CbGpPWpGaD
Montelukast—Nervous system disorder—Docetaxel—head and neck cancer	0.000714	0.00392	CcSEcCtD
Montelukast—Pruritus—Fluorouracil—head and neck cancer	0.000714	0.00392	CcSEcCtD
Montelukast—Thrombocytopenia—Docetaxel—head and neck cancer	0.000713	0.00392	CcSEcCtD
Montelukast—Skin disorder—Docetaxel—head and neck cancer	0.000707	0.00389	CcSEcCtD
Montelukast—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000706	0.00495	CbGpPWpGaD
Montelukast—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000695	0.00488	CbGpPWpGaD
Montelukast—Diarrhoea—Fluorouracil—head and neck cancer	0.00069	0.00379	CcSEcCtD
Montelukast—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000688	0.00483	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000685	0.00481	CbGpPWpGaD
Montelukast—Dizziness—Fluorouracil—head and neck cancer	0.000667	0.00367	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000663	0.00364	CcSEcCtD
Montelukast—Insomnia—Docetaxel—head and neck cancer	0.000658	0.00362	CcSEcCtD
Montelukast—Paraesthesia—Docetaxel—head and neck cancer	0.000654	0.00359	CcSEcCtD
Montelukast—CYSLTR1—GPCR downstream signaling—GRP—head and neck cancer	0.000651	0.00457	CbGpPWpGaD
Montelukast—Somnolence—Docetaxel—head and neck cancer	0.000647	0.00356	CcSEcCtD
Montelukast—Vomiting—Fluorouracil—head and neck cancer	0.000641	0.00352	CcSEcCtD
Montelukast—Dyspepsia—Docetaxel—head and neck cancer	0.000641	0.00352	CcSEcCtD
Montelukast—Rash—Fluorouracil—head and neck cancer	0.000636	0.00349	CcSEcCtD
Montelukast—Dermatitis—Fluorouracil—head and neck cancer	0.000635	0.00349	CcSEcCtD
Montelukast—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000634	0.00445	CbGpPWpGaD
Montelukast—Headache—Fluorouracil—head and neck cancer	0.000632	0.00347	CcSEcCtD
Montelukast—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000628	0.00345	CcSEcCtD
Montelukast—Fatigue—Docetaxel—head and neck cancer	0.000628	0.00345	CcSEcCtD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000624	0.00438	CbGpPWpGaD
Montelukast—Pain—Docetaxel—head and neck cancer	0.000622	0.00342	CcSEcCtD
Montelukast—Nausea—Fluorouracil—head and neck cancer	0.000599	0.00329	CcSEcCtD
Montelukast—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000595	0.00327	CcSEcCtD
Montelukast—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000595	0.00417	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—GRP—head and neck cancer	0.000591	0.00415	CbGpPWpGaD
Montelukast—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000587	0.00412	CbGpPWpGaD
Montelukast—Body temperature increased—Docetaxel—head and neck cancer	0.000575	0.00316	CcSEcCtD
Montelukast—Abdominal pain—Docetaxel—head and neck cancer	0.000575	0.00316	CcSEcCtD
Montelukast—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000566	0.00397	CbGpPWpGaD
Montelukast—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00056	0.00393	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000547	0.00384	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.00054	0.00379	CbGpPWpGaD
Montelukast—Hypersensitivity—Docetaxel—head and neck cancer	0.000536	0.00295	CcSEcCtD
Montelukast—Asthenia—Docetaxel—head and neck cancer	0.000522	0.00287	CcSEcCtD
Montelukast—Pruritus—Docetaxel—head and neck cancer	0.000515	0.00283	CcSEcCtD
Montelukast—Diarrhoea—Docetaxel—head and neck cancer	0.000498	0.00274	CcSEcCtD
Montelukast—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000497	0.00349	CbGpPWpGaD
Montelukast—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000484	0.0034	CbGpPWpGaD
Montelukast—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000482	0.00338	CbGpPWpGaD
Montelukast—Dizziness—Docetaxel—head and neck cancer	0.000481	0.00265	CcSEcCtD
Montelukast—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000478	0.00335	CbGpPWpGaD
Montelukast—Vomiting—Docetaxel—head and neck cancer	0.000463	0.00254	CcSEcCtD
Montelukast—Rash—Docetaxel—head and neck cancer	0.000459	0.00252	CcSEcCtD
Montelukast—Dermatitis—Docetaxel—head and neck cancer	0.000459	0.00252	CcSEcCtD
Montelukast—Headache—Docetaxel—head and neck cancer	0.000456	0.00251	CcSEcCtD
Montelukast—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000451	0.00316	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000445	0.00312	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000439	0.00308	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000437	0.00307	CbGpPWpGaD
Montelukast—Nausea—Docetaxel—head and neck cancer	0.000432	0.00238	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—KISS1—head and neck cancer	0.000424	0.00297	CbGpPWpGaD
Montelukast—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000418	0.00294	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000416	0.00292	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000416	0.00292	CbGpPWpGaD
Montelukast—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000409	0.00287	CbGpPWpGaD
Montelukast—CYSLTR1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000404	0.00283	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000403	0.00283	CbGpPWpGaD
Montelukast—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000397	0.00278	CbGpPWpGaD
Montelukast—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000396	0.00278	CbGpPWpGaD
Montelukast—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000395	0.00277	CbGpPWpGaD
Montelukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000392	0.00275	CbGpPWpGaD
Montelukast—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000375	0.00263	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000361	0.00253	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000355	0.00249	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000351	0.00246	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GRP—head and neck cancer	0.000349	0.00245	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—UROD—head and neck cancer	0.000349	0.00245	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT6—head and neck cancer	0.000339	0.00238	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000334	0.00234	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—NAT2—head and neck cancer	0.000334	0.00234	CbGpPWpGaD
Montelukast—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000333	0.00234	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—UROD—head and neck cancer	0.00033	0.00231	CbGpPWpGaD
Montelukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000319	0.00224	CbGpPWpGaD
Montelukast—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000315	0.00221	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—YAP1—head and neck cancer	0.0003	0.0021	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000294	0.00206	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—DPYD—head and neck cancer	0.000293	0.00206	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00029	0.00203	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—YAP1—head and neck cancer	0.000278	0.00195	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000271	0.0019	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.00027	0.0019	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000266	0.00187	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000259	0.00182	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000256	0.0018	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000253	0.00177	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—UROD—head and neck cancer	0.000225	0.00158	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.00022	0.00154	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000217	0.00152	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000209	0.00147	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000208	0.00146	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000206	0.00144	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—UROD—head and neck cancer	0.000183	0.00129	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000182	0.00128	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000175	0.00123	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—IL2—head and neck cancer	0.000173	0.00122	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—TYMS—head and neck cancer	0.000167	0.00117	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTM1—head and neck cancer	0.000165	0.00116	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GPX1—head and neck cancer	0.000158	0.00111	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL2—head and neck cancer	0.000157	0.0011	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP1A1—head and neck cancer	0.000156	0.0011	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000154	0.00108	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000152	0.00107	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000145	0.00102	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NAT2—head and neck cancer	0.000145	0.00102	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000143	0.001	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000142	0.000998	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000137	0.000965	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NAT2—head and neck cancer	0.000137	0.000961	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000136	0.000952	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000135	0.000948	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000128	0.000902	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—DPYD—head and neck cancer	0.000127	0.000891	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—MAPK3—head and neck cancer	0.000127	0.000888	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UROD—head and neck cancer	0.000121	0.000849	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—YAP1—head and neck cancer	0.000121	0.000846	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—MAPK1—head and neck cancer	0.00012	0.000845	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—EGFR—head and neck cancer	0.00012	0.000845	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—DPYD—head and neck cancer	0.00012	0.000843	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000115	0.000808	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—YAP1—head and neck cancer	0.000114	0.0008	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CA—head and neck cancer	0.000105	0.000733	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.94e-05	0.000697	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.84e-05	0.00069	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HRAS—head and neck cancer	9.67e-05	0.000678	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—head and neck cancer	9.4e-05	0.00066	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NAT2—head and neck cancer	9.36e-05	0.000657	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—head and neck cancer	9.3e-05	0.000653	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—head and neck cancer	9.3e-05	0.000653	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCND1—head and neck cancer	9.07e-05	0.000636	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.06e-05	0.000635	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—head and neck cancer	8.75e-05	0.000614	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—head and neck cancer	8.54e-05	0.000599	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—DPYD—head and neck cancer	8.2e-05	0.000576	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—head and neck cancer	8.11e-05	0.000569	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.09e-05	0.000567	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.01e-05	0.000562	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—head and neck cancer	7.9e-05	0.000555	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.9e-05	0.000554	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—head and neck cancer	7.83e-05	0.000549	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—YAP1—head and neck cancer	7.78e-05	0.000546	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NAT2—head and neck cancer	7.61e-05	0.000534	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK3—head and neck cancer	7.48e-05	0.000525	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TYMS—head and neck cancer	7.24e-05	0.000508	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—head and neck cancer	7.15e-05	0.000502	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK1—head and neck cancer	7.11e-05	0.000499	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGFR—head and neck cancer	7.11e-05	0.000499	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPX1—head and neck cancer	6.85e-05	0.000481	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TYMS—head and neck cancer	6.84e-05	0.00048	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP1A1—head and neck cancer	6.78e-05	0.000476	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTM1—head and neck cancer	6.76e-05	0.000475	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—DPYD—head and neck cancer	6.68e-05	0.000469	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPX1—head and neck cancer	6.48e-05	0.000455	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP1A1—head and neck cancer	6.41e-05	0.00045	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—YAP1—head and neck cancer	6.34e-05	0.000445	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—head and neck cancer	6.17e-05	0.000433	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—head and neck cancer	5.97e-05	0.000419	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.85e-05	0.00041	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—head and neck cancer	5.72e-05	0.000402	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HRAS—head and neck cancer	5.71e-05	0.000401	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.57e-05	0.000391	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.1e-05	0.000358	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—head and neck cancer	5.04e-05	0.000354	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NAT2—head and neck cancer	5.02e-05	0.000352	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.76e-05	0.000334	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TYMS—head and neck cancer	4.67e-05	0.000328	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—head and neck cancer	4.67e-05	0.000328	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—head and neck cancer	4.62e-05	0.000324	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPX1—head and neck cancer	4.43e-05	0.000311	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—DPYD—head and neck cancer	4.4e-05	0.000309	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP1A1—head and neck cancer	4.38e-05	0.000307	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—YAP1—head and neck cancer	4.18e-05	0.000293	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.15e-05	0.000291	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—head and neck cancer	4.03e-05	0.000283	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—head and neck cancer	3.81e-05	0.000268	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TYMS—head and neck cancer	3.8e-05	0.000267	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.76e-05	0.000264	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPX1—head and neck cancer	3.6e-05	0.000253	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.6e-05	0.000253	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP1A1—head and neck cancer	3.57e-05	0.00025	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—head and neck cancer	3.52e-05	0.000247	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—head and neck cancer	3.33e-05	0.000233	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.93e-05	0.000206	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—head and neck cancer	2.61e-05	0.000183	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TYMS—head and neck cancer	2.51e-05	0.000176	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—head and neck cancer	2.48e-05	0.000174	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.48e-05	0.000174	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPX1—head and neck cancer	2.38e-05	0.000167	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.35e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—head and neck cancer	2.35e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—head and neck cancer	2.27e-05	0.000159	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.12e-05	0.000149	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—head and neck cancer	2.03e-05	0.000142	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—head and neck cancer	1.92e-05	0.000135	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—head and neck cancer	1.85e-05	0.00013	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.6e-05	0.000112	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.4e-05	9.81e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—head and neck cancer	1.31e-05	9.19e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.3e-05	9.15e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—head and neck cancer	1.22e-05	8.56e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—head and neck cancer	1.07e-05	7.48e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.6e-06	6.04e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—head and neck cancer	7.03e-06	4.93e-05	CbGpPWpGaD
